Physician profile
William E Alison
NPI 1225089030
$3,807.24
in general payments reported to CMS, 2019-2025
11 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,555 · 2020: $261 · 2021: $270 · 2022: $210 · 2023: $327 · 2024: $760 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,510.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,671.99 | 2019-2022 | |
| Abbvie INC. | $669.97 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Revance Therapeutics, INC. | $615.02 | 2024-2025 | Daxxify |
| Sientra, INC. | $473.84 | 2019-2021 | |
| Novo Nordisk INC | $106.97 | 2021 | |
| Kerecis Limited | $100.32 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Motiva USA, LLC | $68.64 | 2024-2025 | |
| Integra Lifesciences Corporation | $41.12 | 2023 | Durasorb Monofilament Mesh |
| Acelrx Pharmaceuticals, INC. | $30.42 | 2022 | |
| Mentor Worldwide LLC | $15.63 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Pacira Pharmaceuticals Incorporated | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Alison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.